PHARMAENGINE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.3 TWD | 0.00% |
|
-0.53% | -11.56% |
| 02/05 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 24/04 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
Chart calendar PharmaEngine, Inc.
50fb5920233002f33eff10fa5ebf6.vA5G35vObvseBGxiNwiPO71ANFp2epuiUTCKbPLQyTM.5DYSiq2PX60zN189W17KaNoGXT4kH_DAF0T6OsCDhQL_anG36KwInU1cOQ~c93432c0272892870748e00059227d52
Upcoming events on PharmaEngine, Inc.
No events available
Past events on PharmaEngine, Inc.
| 09/06/2020 06:30 am | Annual General Meeting |
| 13/06/2019 06:30 am | Annual General Meeting |
| 10/01/2019 | J.P. Morgan Healthcare Conference |
| 12/06/2018 | Annual General Meeting |
Past dividends on PharmaEngine, Inc.
| 15/08/2023 | Annual 2 TWD |
| 15/08/2022 | Annual 2.7 TWD |
| 13/09/2021 | Annual 2.534819 TWD |
| 28/07/2020 | Annual 0.50024 TWD |
| 28/08/2019 | Annual 1 TWD |
| 27/08/2018 | Annual 2 TWD |
| 26/07/2017 | Annual 1.999526 TWD |
| 26/07/2017 | 0.499881 TWD |
| 25/07/2016 | Annual 0.999596 TWD |
| 25/07/2016 | 0.999596 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 314 384 -18.22% | 1 056 384 175% | 655 657 -0.25% | 654 656 -0.25% | 768 766 0.22% | 845 |
|
EBITDA Million TWD | Released Forecast Spread | 39,3 76,0 -48.27% | 822 151 444.55% | 373 216 72.66% | 0,00 0,00 - | 0,00 0,00 - | 419 |
|
EBIT Million TWD | Released Forecast Spread | 32,6 56,5 -42.28% | 810 144 462.3% | 363 265 36.86% | 283 257 10.02% | 277 282 -1.71% | 374 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 49,7 142 -65.02% | 752 137 451.26% | 545 345 58.09% | 392 278 41.17% | 338 355 -4.8% | 448 |
|
Net income Million TWD | Released Forecast Spread | 42,6 115 -62.84% | 604 111 446.86% | 426 267 59.86% | 319 219 45.56% | 275 304 -9.65% | 361 |
|
EPS TWD | Released Forecast Spread | 0,29 0,78 -62.66% | 4,14 0,75 451.6% | 2,94 1,81 62.1% | 2,22 1,50 48% | 1,91 2,09 -8.61% | 2,48 |
| Announcement Date | 18/03/20 | 21/03/21 | 08/03/22 | 17/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 174 174 0.36% | 167 167 -0.06% | 155 155 -0.08% | 158 160 -0.95% | 168 178 -5.43% | 246 246 -0.02% | 187 186 0.71% | 164 180 -8.63% | 184 | 243 | 254 | 179 | 206 | |
|
EBIT Million TWD | Released Forecast Spread | 117 109 7.49% | 97,2 97,0 0.23% | 19,3 19,0 1.45% | 49,6 24,0 106.75% | 81,1 166 -51.15% | 77,5 78,0 -0.62% | 65,2 70,0 -6.91% | 67,4 65,0 3.66% | 79,0 | 114 | 141 | 81,0 | 97,0 | |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 122 118 3.49% | 104 104 0.27% | 102 23,0 342.2% | 64,4 28,0 129.85% | 102 78,0 31.35% | 103 103 0.06% | 60,2 77,0 -21.76% | 103 84,0 22.32% | 97,0 | 126 | 149 | 99,0 | 120 | |
|
Net income Million TWD | Released Forecast Spread | 97,0 93,0 4.34% | 80,7 81,0 -0.41% | 87,5 19,0 360.33% | 53,6 22,0 143.71% | 81,4 63,0 29.17% | 75,1 | 80,8 81,0 -0.27% | 37,4 67,0 -44.22% | 81,7 72,0 13.51% | 78,0 | 101 | 122 | 81,0 | 97,0 |
|
EPS TWD | Released Forecast Spread | 0,68 0,64 6.25% | 0,56 0,56 0% | 0,61 0,13 369.23% | 0,37 0,15 146.67% | 0,57 0,43 32.56% | 0,52 | 0,56 0,56 0% | 0,26 0,46 -43.48% | 0,57 0,49 16.33% | 0,54 | 0,69 | 0,84 | 0,56 | 0,67 |
| Announcement Date | 06/05/22 | 03/08/22 | 04/11/22 | 17/03/23 | 04/05/23 | 04/08/23 | 06/11/23 | 29/02/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for PharmaEngine, Inc.
| 10/05/2024 04:30 pm | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 10/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:40 am | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | OMNIAB, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4162 Stock
- Calendar PharmaEngine, Inc.